PWMG
BHVN

Pinnacle Wealth Management Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Pinnacle Wealth Management Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,600
Closed -$242K – 111
2022
Q3 		$242K Hold
1,600
– – 0.21% 92
2022
Q2 		$233K Buy
+1,600
New +$204K 0.2% 103
2022
Q1 		– Sell
-1,600
Closed -$220K – 136
2021
Q4 		$220K Buy
+1,600
New +$203K 0.16% 114

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Pinnacle Wealth Management Group's BHVN Position: Q4 2022 in Review

Pinnacle Wealth Management Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,600 shares — an estimated $242K sold.

Pinnacle Wealth Management Group first reported a position in BHVN in Q4 2021 and held it in 3 quarters. The position peaked at $242K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Pinnacle Wealth Management Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Pinnacle Wealth Management Group sold 1,600 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $242K.
  • Pinnacle Wealth Management Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2021 and held it in 3 quarters.
  • Pinnacle Wealth Management Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $242K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Pinnacle Wealth Management Group's 13F filing for Q4 2022, filed 9 Jan 2023.